These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37467378)

  • 1. Descriptive Characterization of High-Frequency Distortion Product Otoacoustic Emission Source Components in Children.
    Dreisbach L; Konrad-Martin D; Gagner C; Reavis KM; Jacobs PG
    J Speech Lang Hear Res; 2023 Aug; 66(8):2950-2966. PubMed ID: 37467378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Variability of Distortion-Product Otoacoustic Emissions in Infants and Children and Its Relation to Pediatric Ototoxicity Monitoring.
    Konrad-Martin D; Knight K; McMillan GP; Dreisbach LE; Nelson E; Dille M
    Ear Hear; 2020; 41(2):239-253. PubMed ID: 29280917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.
    Dreisbach LE; Long KM; Lees SE
    Ear Hear; 2006 Oct; 27(5):466-79. PubMed ID: 16957498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Frequency Distortion-Product Otoacoustic Emission Repeatability in a Patient Population.
    Dreisbach L; Zettner E; Chang Liu M; Meuel Fernhoff C; MacPhee I; Boothroyd A
    Ear Hear; 2018; 39(1):85-100. PubMed ID: 28678077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
    Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion product otoacoustic emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates.
    Abdala C
    J Acoust Soc Am; 1996 Dec; 100(6):3726-40. PubMed ID: 8969474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliable Long-Term Serial Evaluation of Cochlear Function Using Pulsed Distortion-Product Otoacoustic Emissions: Analyzing Levels and Pressure Time Courses.
    Bader K; Dalhoff E; Dierkes L; Braun LH; Gummer AW; Zelle D
    Ear Hear; 2024 Sep-Oct 01; 45(5):1326-1338. PubMed ID: 38809242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of calibration method on distortion-product otoacoustic emission measurements: II. threshold prediction.
    Rogers AR; Burke SR; Kopun JG; Tan H; Neely ST; Gorga MP
    Ear Hear; 2010 Aug; 31(4):546-54. PubMed ID: 20458245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative Middle Ear Pressure and Composite and Component Distortion Product Otoacoustic Emissions.
    Thompson S; Henin S; Long GR
    Ear Hear; 2015; 36(6):695-704. PubMed ID: 26049553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test-retest reliability of distortion-product thresholds compared to behavioral auditory thresholds.
    Bader K; Dierkes L; Braun LH; Gummer AW; Dalhoff E; Zelle D
    Hear Res; 2021 Jul; 406():108232. PubMed ID: 33984603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of neonatal hearing impairment: distortion product otoacoustic emissions during the perinatal period.
    Gorga MP; Norton SJ; Sininger YS; Cone-Wesson B; Folsom RC; Vohr BR; Widen JE; Neely ST
    Ear Hear; 2000 Oct; 21(5):400-24. PubMed ID: 11059701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the 2f
    Wen H; Bowling T; Meaud J
    Hear Res; 2018 Aug; 365():127-140. PubMed ID: 29801982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Optimal Stimulus Frequency Ratio for Measurement of the Quadratic f2-f1 Distortion Product Otoacoustic Emission in Humans.
    Baiduc RR; Dhar S
    J Speech Lang Hear Res; 2018 Jul; 61(7):1794-1806. PubMed ID: 29946695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender effects on high frequency distortion product otoacoustic emissions in humans.
    Dunckley KT; Dreisbach LE
    Ear Hear; 2004 Dec; 25(6):554-64. PubMed ID: 15604916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of calibration method on distortion-product otoacoustic emission measurements: I. test performance.
    Burke SR; Rogers AR; Neely ST; Kopun JG; Tan H; Gorga MP
    Ear Hear; 2010 Aug; 31(4):533-45. PubMed ID: 20458246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for two discrete sources of 2f1-f2 distortion-product otoacoustic emission in rabbit. II: Differential physiological vulnerability.
    Whitehead ML; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1992 Nov; 92(5):2662-82. PubMed ID: 1479129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.